Hemcheck ensures that hemolyzed blood samples are quickly and easily detected at the time of sampling.

See full video


Services

Hemcheck contributes to better care flow, reduced costs and, above all, increased patient safety.

Read more

Health Economic Analysis

Create your own Health Economic Analysis.

Read more

Investors

Hemcheck is listed on Nasdaq First North Growth Market. Are you interested in more financial information about the company?

Read more

The product concept

All HemCheck operations are based on the development of the Helge product concept. The product consists of two different disposable tests, s-Test for blood gas syringes and v-Test for test tubes, and a common reader that quickly and easily determines whether the blood sample is hemolyzed or not. The aim is to find hemolyzed blood samples in a few seconds directly after the point-of-care (blood-sampling) test.


About Hemcheck 2020

News and Press releases

Subscription agreement signed with Tartu university hospital in Estonia

2020-10-20

Read more...

Evaluation agreement with Hemakim regarding potential distribution in Turkey extended to the end of 2020

2020-09-30

Read more...

UK NICE has published a Medtech Innovation Briefing on Hemcheck’s point of care hemolysis detection technology

2020-09-02

Read more...

Hemcheck has selected Medscaler and Medicen as partners within the Bridgehead program, focusing on commercial development in the Netherlands and France

2020-08-28

Read more...

Agreement with Foundation for Innovative New Diagnostics (FIND)

2020-07-13

Read more...

Events

Nov

06

Baltic Congress in Laboratory Medicine

Riga

Nov

10

Equalis user meeting – Clinical chemistry

Digital

Nov

16

MEDICA

Dusseldorf

Nov

20

Annual Meeting of the Royal Belgian Society for Laboratory Medicine

Brussels

Prenumerera på vårt nyhetsbrev

Jag accepterar hemcheck.com integritetsvillkor

Create your own

health economic analysis!